Company intelligence / Profile preview

Tesla

Unknown*, Pennsylvania?, USAtesla.com ↗

Ownership: Public · TSLA
Development stage: Commercial

Overview

Tesla BioHealing develops and commercializes proprietary biophoton-based medical devices aimed at enhancing the body's natural healing processes. In September 2024, it partnered with Cell Biotechnology to accelerate research and clinical development of advanced autologous stem cell therapies using its platform. The collaboration aims to improve patient outcomes by increasing the availability and effectiveness of regenerative treatments. Clinical trials are being accelerated through this alliance.

Therapeutic areas: Other
Modalities: Device (Biophoton technology)Cell therapy (via partnership for stem cell therapies)
Industry: Therapeutic Medical Devices

Partnerships

Cell Biotechnology Co., Ltd. (Osaka, Japan): Joint R&D/commercialization for advanced autologous stem cell therapies using biophoton technology.

Financials

Market cap: $1.5T
Total revenue: $28.2B
Enterprise value: $1.4T

Beyond the preview

Go deeper on Tesla.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tesla.

Explore the full profile